Helios University Hospital Wuppertal
5
0
0
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 5 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
33%
1 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (5)
EORTC Quality of Life Measurement in Males With Breast Cancer
Role: lead
An International Field Study of the Reliability and Validity of a Disease-Specific Questionnaire Module (the QLQ-OV28) in Assessing the Quality of Life of Patients With Ovarian Cancer - Phase III
Role: lead
Comparative Effectiveness Study of Transthoracic and Transesophageal Echocardiography in Stroke
Role: collaborator
Psychometric Properties of the Updated Module on Assessing Quality of Life of Patients With Breast Cancer
Role: lead
Impact of Transcatheter Aortic Valve Implantation (TAVI) on Cognitive Functions
Role: lead
All 5 trials loaded